45 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Immuron Limited IMRN shares jumped 71.2 percent to $14.46 after the company disclosed positive results in NASH clinical trial.
• PCM Inc PCMI surged 39.5 percent to $11.30 following Q4 results.
• Net Element International Inc NETE shares rose 21.9 percent to $7.45. Net Element named Jon Najarian to its board.
• Oragenics Inc OGEN gained 20.2 percent to $3.14 after surging 34.54 percent on Wednesday.
• Comtech Telecomm. Corp. CMTL shares jumped 18.5 percent to $28.75 after reporting upbeat quarterly results.
• Bravo Brio Restaurant Group, Inc. BBRG rose 15.4 percent to $4.00 after the company agreed to be acquired for $4.05 per share in cash.
• Jounce Therapeutics Inc JNCE climbed 15 percent to $25.12. Jounce Therapeutics reported a Q4 loss of $0.29 per share on sales of $13 million.
• United Microelectronics Corp (ADR) UMC shares gained 11.6 percent to $2.70.
• Progenics Pharmaceuticals, Inc. PGNX rose 11.5 percent to $8.05 following Q4 results.
• Express Scripts Holding Company ESRX gained 11.1 percent to $81.54. CIGNA Corporation CI announced plans to acquire Express Scripts for $67 billion.
• Zosano Pharma Corp ZSAN climbed 10.8 percent to $16.10 after gaining more than 55 percent Wednesday.
• Orion Group Holdings Inc ORN gained 10.4 percent to $6.99 following upbeat quarterly earnings.
• Reis Inc REIS rose 10.1 percent to $21.90 as the company announced plans to explore strategic alternatives.
• Anavex Life Sciences Corp. AVXL climbed 9.4 percent to $3.16.
• Discovery Communications Inc. DISCB shares rose 7.9 percent to $30.20.
• Diplomat Pharmacy Inc DPLO climbed 7.8 percent to $22.66. Barclays initiated coverage on Diplomat Pharmacy with an Overweight rating and a $27.00 price target.
• Burlington Stores Inc BURL gained 6.7 percent to $123.89 after the company reported upbeat earnings for its fourth quarter.
• Innovate Biopharmaceuticals Inc INNT rose 6.5 percent to $13.84 after falling 10.34 percent on Wednesday.
• Stage Stores Inc SSI rose 6.3 percent to $2.02. Stage Stores reported Q4 adjusted earnings of $0.45 per share on sales of $549 million.
• Intellia Therapeutics Inc NTLA gained 6 percent to $31.18. JMP Securities initiates coverage on Intellia Therapeutics with a Market Outperform rating and a $76.00 price target.
• Genocea Biosciences Inc GNCA rose 5.9 percent to $1.17. H.C. Wainwright initiated coverage on Genocea Biosciences with a Buy rating and a $5.00 price target.
• International Game Technology IGT gained 5.1 percent to $29.04 after the company reported Q4 results.
• Wynn Resorts, Limited WYNN rose 4.1 percent to $175.34 following news of dividend raise and QTD results from Vegas and Macau Properties.
• Shiloh Industries, Inc. SHLO shares gained 3.7 percent to $8.41 following upbeat quarterly results.

Check out these big penny stock gainers and losers

Losers

• Vascular Biogenics Ltd VBLT shares dipped 61.4 percent to $2.62 after the company disclosed that its Phase 3 GLOBE study did not meet its pre-specified primary endpoint of overall survival.
• Volt Information Sciences, Inc. VISI fell 36.4 percent to $2.45. Volt Info Sciences reported a Q1 loss of $0.51 per share on sales of $253.338 million.
• FTD Companies Inc FTD declined 35.1 percent to $4.38 after the company reported preliminary financial results for the full-year ended December 31, 2017 and updated its 2018 business forecast.
• tronc Inc TRNC fell 22.6 percent to $15.35 after reporting Q4 results.
• Meet Group Inc MEET fell 21.3 percent to $2.51 after the company posted Q4 results.
• Zagg Inc ZAGG dipped 20.2 percent to $12.38 after the company posted downbeat quarterly earnings.
• Tech Data Corp TECD fell 19.4 percent to $86.78 after the company issued a weak forecast for the current quarter.
• Myomo Inc MYO fell 16.4 percent to $4.23. Myomo reported a Q4 loss of $0.25 per share on sales of $547,000.
• XOMA Corporation XOMA dropped 16.1 percent to $23.96. XOMA reported a Q4 loss of $0.16 per share on sales of $5.357 million. The company also announced a $300 million mixed securities shelf offering.
• Foundation Medicine Inc FMI fell 12.9 percent to $72.51 following wider-than-expected Q4 loss.
• BioScrip Inc BIOS declined 12.5 percent to $2.68 following Q4 results.
• Viking Therapeutics Inc VKTX fell 12.2 percent to $5.27. Viking Therapeutics reported a Q4 loss of $0.14 per share.
• Kroger Co KR fell 12.1 percent to $23.07. Kroger posted in-line Q4 earnings.
• Catasys, Inc. CATS dropped 10.7 percent to $4.76.
• NN, Inc. NNBR shares slipped 10.5 percent to $ 23.80 following downbeat quarterly earnings.
• Checkpoint Therapeutics Inc CKPT shares fell 10.3 percent to $4.79 after the company reported a proposed public offering of common stock.
• CIGNA Corporation CI slipped 10 percent to $174.79 as the company announced plans to acquire Express Scripts for $67 billion.
• Fairmount Santrol Holdings Inc FMSA shares fell 8.6 percent to $4.11 following weak Q4 results.
• ShiftPixy Inc PIXY fell 8.4 percent to $3.91 after gaining 66.15 percent on Wednesday.
• CalAmp Corp. CAMP dropped 6 percent to $ 23.29. Craig-Hallum downgraded CalAmp from Buy to Hold.
• Corvus Pharmaceuticals Inc CRVS fell 5 percent to $9.05 after reporting an offering of $50 million in common shares.